Clinical utility gene card for: Dyskeratosis congenita-update 2015

European Journal of Human Genetics

Volumn 23, Issue 4, 2015, Pages e2-e4

  Dokal, Inderjeet ^a   Vulliamy, Tom ^a   Mason, Philip ^b   Bessler, Monica ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CTC1 PROTEIN, HUMAN; DKC1 PROTEIN, HUMAN; DNA HELICASE; NHP2 PROTEIN, HUMAN; NOP10 PROTEIN, HUMAN; NUCLEAR PROTEIN; PHOSPHODIESTERASE; RNA; RTEL1 PROTEIN, HUMAN; SMALL NUCLEAR RIBONUCLEOPROTEIN; SMALL NUCLEOLAR RIBONUCLEOPROTEIN; TELOMERASE; TELOMERASE CAJAL BODY PROTEIN 1, HUMAN; TELOMERASE RNA; TELOMERE BINDING PROTEIN; TERT PROTEIN, HUMAN; TINF2 PROTEIN, HUMAN; USB1 PROTEIN, HUMAN;

DNA FRAGMENTATION; DYSKERATOSIS CONGENITA; GENETIC SCREENING; GENETICS; HUMAN; SENSITIVITY AND SPECIFICITY;

CELL CYCLE PROTEINS; DNA FRAGMENTATION; DNA HELICASES; DYSKERATOSIS CONGENITA; GENETIC TESTING; HUMANS; NUCLEAR PROTEINS; PHOSPHORIC DIESTER HYDROLASES; RIBONUCLEOPROTEINS, SMALL NUCLEAR; RIBONUCLEOPROTEINS, SMALL NUCLEOLAR; RNA; SENSITIVITY AND SPECIFICITY; TELOMERASE; TELOMERE-BINDING PROTEINS;

EID: 85027935882     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/EJHG.2014.170     Document Type: Article

References (11)

1. Alter BP, Baerlocher GM, Savage SA et al: Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood 2007; 110: 1439-1447.
2. Bessler M, Wilson BD, Mason PJ: Dyskeratosis congenita. FEBS Letts 2010; 584: 3831-3838.
3. Calado RT, Young NS: Telomere Diseases. N Engl J Med 2009; 361: 2353-2365.
4. Dokal I: Dyskeratosis Congenita. Hematol Am Soc Hematol Edu Program 2011; 2011: 480-486.
5. Du HY, Pumbo E, Ivanovich J et al: TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood 2009; 113: 309-316.
6. Fogarty PF, Yamaguchi H, Wiestner A et al: Late presentation of dyskeratosis congenita as apparently acquired aplstic anaemia due to mutations in telomerase RNA. Lancet 2003; 362: 1628-1630.
7. Gramatges MM, Bertuch AA: Short telomeres: From dyskeratosis congenita to sporadic aplastic anemia and malignancy. Transl Res 2013; 162: 353-363.
8. Savage SA, Dokal I, Armanios M et al: Dyskeratosis congenita: The first NIH clinical research workshop. Pediatr Blood Cancer 2009; 53: 520-523.
9. Vulliamy TJ, Knight SW, Mason PJ, Dokal I. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol Dis 2001; 27: 3 53-77.
10. Vulliamy TJ, Marrone M, Knight S, Walne A, Mason PJ, Dokal I: Mutations in dyskeratosis congenita: Their impact on telomere length and the diversity of clinical presentation. Blood 2006; 107: 2680-2685.
11. Walne AJ, Dokal I: Advances in the understanding of Dyskeratosis Congenita. Br J Haematol 2009; 145: 164-172.